Indications of Bortezomib injection
Created 1 week ago by anniepery

Bortezomib is an anti-cancer medication indicated for treating multiple myeloma and mantle cell lymphoma. The drug Bortezomib is a Proteasome Inhibitor; it works by inhibiting or blocking proteasomes, cellular complexes that break down proteins. The general recommended dosage of Bortezomib by healthcare professionals is 2mg/ 3.5mg, the Bortezomib injection is administered intravenously or subcutaneously. The active ingredient in the medicine is Bortezomib, and the inactive ingredient is mannitol. Bortezomib injection is reasonable in India, and one can readily find it with multiple certified suppliers. For more information, call 18008891064.